$40.13
0.44[1.11%]
Last update: 10:24AM Get Real Time Here
QuidelOrtho
(NASDAQ:QDEL)QuidelOrtho Stock (NASDAQ:QDEL), Analyst Ratings, Price Targets, Predictions
QuidelOrtho Corp has a consensus price target of $52.67, established from looking at the 29 latest analyst ratings. The last 3 analyst ratings were released from UBS, Craig-Hallum, and RBC Capital on March 4, 2024, February 14, 2024, and February 14, 2024. With an average price target of $41 between UBS, Craig-Hallum, and RBC Capital, there's an implied 2.17% upside for QuidelOrtho Corp from these 3 analyst ratings.
Analyst Firms Making Recommendations1
UBS
Craig-Hallum
RBC Capital
Raymond James
William Blair
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for QuidelOrtho
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 03/04/2024 | QDEL | Buy Now | QuidelOrtho | $40.13 | 4.66% | UBS | John Sourbeer | $70 → $42 | Downgrade | Neutral → Sell | Get Alert |
| 02/14/2024 | QDEL | Buy Now | QuidelOrtho | $40.13 | — | Craig-Hallum | Alexander Nowak | — | Downgrade | Buy → Hold | Get Alert |
| 02/14/2024 | QDEL | Buy Now | QuidelOrtho | $40.13 | 101.84% | RBC Capital | Conor McNamara | $130 → $81 | Maintains | Outperform | Get Alert |
| 02/14/2024 | QDEL | Buy Now | QuidelOrtho | $40.13 | 89.38% | Raymond James | Andrew Cooper | $100 → $76 | Downgrade | Strong Buy → Outperform | Get Alert |
| 02/14/2024 | QDEL | Buy Now | QuidelOrtho | $40.13 | — | William Blair | Andrew Brackmann | — | Downgrade | Outperform → Market Perform | Get Alert |
| 02/14/2024 | QDEL | Buy Now | QuidelOrtho | $40.13 | -7.8% | JP Morgan | Casey Woodring | $66 → $37 | Downgrade | Neutral → Underweight | Get Alert |
| 12/21/2023 | QDEL | Buy Now | QuidelOrtho | $40.13 | 223.95% | RBC Capital | Conor McNamara | $140 → $130 | Maintains | Outperform | Get Alert |
| 12/11/2023 | QDEL | Buy Now | QuidelOrtho | $40.13 | 79.42% | Citigroup | Patrick Donnelly | $95 → $72 | Downgrade | Buy → Neutral | Get Alert |
| 11/02/2023 | QDEL | Buy Now | QuidelOrtho | $40.13 | 149.19% | Raymond James | Andrew Cooper | $110 → $100 | Maintains | Strong Buy | Get Alert |
| 09/19/2023 | QDEL | Buy Now | QuidelOrtho | $40.13 | 248.87% | RBC Capital | Conor McNamara | → $140 | Reiterates | Outperform → Outperform | Get Alert |
| 08/15/2023 | QDEL | Buy Now | QuidelOrtho | $40.13 | 174.11% | Raymond James | Andrew Cooper | $130 → $110 | Maintains | Strong Buy | Get Alert |
| 08/09/2023 | QDEL | Buy Now | QuidelOrtho | $40.13 | 111.81% | JP Morgan | Casey Woodring | $91 → $85 | Maintains | Neutral | Get Alert |
| 08/09/2023 | QDEL | Buy Now | QuidelOrtho | $40.13 | 238.9% | RBC Capital | Conor McNamara | → $136 | Reiterates | Outperform → Outperform | Get Alert |
| 05/04/2023 | QDEL | Buy Now | QuidelOrtho | $40.13 | 231.42% | RBC Capital | Conor McNamara | $130 → $133 | Maintains | Outperform | Get Alert |
| 02/16/2023 | QDEL | Buy Now | QuidelOrtho | $40.13 | 238.9% | RBC Capital | Conor McNamara | $125 → $136 | Maintains | Outperform | Get Alert |
| 02/16/2023 | QDEL | Buy Now | QuidelOrtho | $40.13 | 223.95% | Raymond James | Andrew Cooper | $136 → $130 | Maintains | Strong Buy | Get Alert |
| 12/12/2022 | QDEL | Buy Now | QuidelOrtho | $40.13 | 211.49% | Citigroup | Patrick Donnelly | $90 → $125 | Upgrade | Neutral → Buy | Get Alert |
| 12/07/2022 | QDEL | Buy Now | QuidelOrtho | $40.13 | 211.49% | RBC Capital | Conor McNamara | → $125 | Initiates | → Outperform | Get Alert |
| 11/03/2022 | QDEL | Buy Now | QuidelOrtho | $40.13 | 131.75% | JP Morgan | Casey Woodring | $100 → $93 | Maintains | Neutral | Get Alert |
FAQ
What is the target price for QuidelOrtho (QDEL)?
The latest price target for QuidelOrtho (NASDAQ: QDEL) was reported by UBS on March 4, 2024. The analyst firm set a price target for $42.00 expecting QDEL to rise to within 12 months (a possible 4.66% upside). 14 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for QuidelOrtho (QDEL)?
The latest analyst rating for QuidelOrtho (NASDAQ: QDEL) was provided by UBS, and QuidelOrtho downgraded their sell rating.
When was the last upgrade for QuidelOrtho (QDEL)?
The last upgrade for QuidelOrtho Corp happened on December 12, 2022 when Citigroup raised their price target to $125. Citigroup previously had a neutral for QuidelOrtho Corp.
When was the last downgrade for QuidelOrtho (QDEL)?
The last downgrade for QuidelOrtho Corp happened on March 4, 2024 when UBS changed their price target from $70 to $42 for QuidelOrtho Corp.
When is the next analyst rating going to be posted or updated for QuidelOrtho (QDEL)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of QuidelOrtho, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for QuidelOrtho was filed on March 4, 2024 so you should expect the next rating to be made available sometime around March 4, 2025.
Is the Analyst Rating QuidelOrtho (QDEL) correct?
While ratings are subjective and will change, the latest QuidelOrtho (QDEL) rating was a downgraded with a price target of $70.00 to $42.00. The current price QuidelOrtho (QDEL) is trading at is $40.13, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.